582 related articles for article (PubMed ID: 25609493)
21. Laminin alpha 2 enables glioblastoma stem cell growth.
Lathia JD; Li M; Hall PE; Gallagher J; Hale JS; Wu Q; Venere M; Levy E; Rani MR; Huang P; Bae E; Selfridge J; Cheng L; Guvenc H; McLendon RE; Nakano I; Sloan AE; Phillips HS; Lai A; Gladson CL; Bredel M; Bao S; Hjelmeland AB; Rich JN
Ann Neurol; 2012 Nov; 72(5):766-78. PubMed ID: 23280793
[TBL] [Abstract][Full Text] [Related]
22. The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?
Plaks V; Kong N; Werb Z
Cell Stem Cell; 2015 Mar; 16(3):225-38. PubMed ID: 25748930
[TBL] [Abstract][Full Text] [Related]
23. The three-layer concentric model of glioblastoma: cancer stem cells, microenvironmental regulation, and therapeutic implications.
Persano L; Rampazzo E; Della Puppa A; Pistollato F; Basso G
ScientificWorldJournal; 2011; 11():1829-41. PubMed ID: 22125441
[TBL] [Abstract][Full Text] [Related]
24. Therapy-resistant tumor microvascular endothelial cells contribute to treatment failure in glioblastoma multiforme.
Borovski T; Beke P; van Tellingen O; Rodermond HM; Verhoeff JJ; Lascano V; Daalhuisen JB; Medema JP; Sprick MR
Oncogene; 2013 Mar; 32(12):1539-48. PubMed ID: 22614016
[TBL] [Abstract][Full Text] [Related]
25. [What's next in glioblastoma treatment: Tumor-targeted or immune-targeted therapies?].
Schernberg A; Marabelle A; Massard C; Armand JP; Dumont S; Deutsch E; Dhermain F
Bull Cancer; 2016 May; 103(5):484-98. PubMed ID: 27032303
[TBL] [Abstract][Full Text] [Related]
26. [New treatment strategies targeting cancer stem cells].
Li M
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Oct; 36(5):546-50. PubMed ID: 25360656
[TBL] [Abstract][Full Text] [Related]
27. Glioma stem cell maintenance: the role of the microenvironment.
Heddleston JM; Hitomi M; Venere M; Flavahan WA; Yang K; Kim Y; Minhas S; Rich JN; Hjelmeland AB
Curr Pharm Des; 2011; 17(23):2386-401. PubMed ID: 21827414
[TBL] [Abstract][Full Text] [Related]
28. Brain tumor stem cells: Molecular characteristics and their impact on therapy.
Schonberg DL; Lubelski D; Miller TE; Rich JN
Mol Aspects Med; 2014 Oct; 39():82-101. PubMed ID: 23831316
[TBL] [Abstract][Full Text] [Related]
29. Contribution of the Microenvironmental Niche to Glioblastoma Heterogeneity.
Ho IAW; Shim WSN
Biomed Res Int; 2017; 2017():9634172. PubMed ID: 28630875
[TBL] [Abstract][Full Text] [Related]
30. Angiogenesis and hypoxia in glioblastoma: a focus on cancer stem cells.
Mongiardi MP
CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):878-83. PubMed ID: 23131159
[TBL] [Abstract][Full Text] [Related]
31. Microenvironment and brain tumor stem cell maintenance: impact of the niche.
Herold-Mende C; Mock A
Anticancer Agents Med Chem; 2014; 14(8):1065-74. PubMed ID: 25175691
[TBL] [Abstract][Full Text] [Related]
32. Targeting cancer stem cells for treatment of glioblastoma multiforme.
Cho DY; Lin SZ; Yang WK; Lee HC; Hsu DM; Lin HL; Chen CC; Liu CL; Lee WY; Ho LH
Cell Transplant; 2013; 22(4):731-9. PubMed ID: 23594862
[TBL] [Abstract][Full Text] [Related]
33. The cancer stem cell niche(s): the crosstalk between glioma stem cells and their microenvironment.
Filatova A; Acker T; Garvalov BK
Biochim Biophys Acta; 2013 Feb; 1830(2):2496-508. PubMed ID: 23079585
[TBL] [Abstract][Full Text] [Related]
34. Glioblastoma Stem Cells and Their Microenvironment.
Sattiraju A; Sai KKS; Mintz A
Adv Exp Med Biol; 2017; 1041():119-140. PubMed ID: 29204831
[TBL] [Abstract][Full Text] [Related]
35. Histological Characterization of the Tumorigenic "Peri-Necrotic Niche" Harboring Quiescent Stem-Like Tumor Cells in Glioblastoma.
Ishii A; Kimura T; Sadahiro H; Kawano H; Takubo K; Suzuki M; Ikeda E
PLoS One; 2016; 11(1):e0147366. PubMed ID: 26799577
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical Detection of Neural Stem Cells and Glioblastoma Stem Cells in the Subventricular Zone of Glioblastoma Patients.
Hira VVV; Molenaar RJ; Breznik B; Lah T; Aronica E; Van Noorden CJF
J Histochem Cytochem; 2021 May; 69(5):349-364. PubMed ID: 33596115
[TBL] [Abstract][Full Text] [Related]
37. Critical multiple angiogenic factors secreted by glioblastoma stem-like cells underline the need for combinatorial anti-angiogenic therapeutic strategies.
Thirant C; Gavard J; Junier MP; Chneiweiss H
Proteomics Clin Appl; 2013 Jan; 7(1-2):79-90. PubMed ID: 23229792
[TBL] [Abstract][Full Text] [Related]
38. Personalized regulation of glioblastoma cancer stem cells based on biomedical technologies: From theory to experiment (Review).
Bryukhovetskiy I; Ponomarenko A; Lyakhova I; Zaitsev S; Zayats Y; Korneyko M; Eliseikina M; Mischenko P; Shevchenko V; Shanker Sharma H; Sharma A; Khotimchenko Y
Int J Mol Med; 2018 Aug; 42(2):691-702. PubMed ID: 29749540
[TBL] [Abstract][Full Text] [Related]
39. [Cancer stem cells in glioblastoma].
Virolle T
Bull Cancer; 2017 Dec; 104(12):1075-1079. PubMed ID: 29153545
[No Abstract] [Full Text] [Related]
40. Mitochondrial NIX Promotes Tumor Survival in the Hypoxic Niche of Glioblastoma.
Jung J; Zhang Y; Celiku O; Zhang W; Song H; Williams BJ; Giles AJ; Rich JN; Abounader R; Gilbert MR; Park DM
Cancer Res; 2019 Oct; 79(20):5218-5232. PubMed ID: 31488423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
